Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression

Psychiatric disorders, psychotropic medication use and falls among women: an observational study

(2015) Lana J Williams et al.   BMC Psychiatry

Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review

(2014) Marie Anne Gebara et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Depression following fracture in women: a study of age-matched cohorts: Table 1

(2014) Lana J Williams et al.   BMJ Open

Selective Serotonin Reuptake Inhibitors Inhibit Human Osteoclast and Osteoblast Formation and Function

(2012) Jason M. Hodge et al.   BIOLOGICAL PSYCHIATRY

Antidepressant medications and osteoporosis

(2012) R. Rizzoli et al.   BONE

Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders

(2012) Lana J. Williams et al.   JOURNAL OF AFFECTIVE DISORDERS

Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis

(2012) Chun-Sick Eom et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Tricyclic antidepressant use and risk of fractures: A meta-analysis of cohort and case-control studies

(2012) Qing Wu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Decreased osteoclastogenesis in serotonin-deficient mice

(2012) Y. Chabbi-Achengli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The adverse skeletal effects of selective serotonin reuptake inhibitors

(2011) E.M. Tsapakis et al.   EUROPEAN PSYCHIATRY

The association between depressive and anxiety symptoms and bone mineral density in the general population: The HUNT Study

(2011) Lana J. Williams et al.   JOURNAL OF AFFECTIVE DISORDERS

Do SSRIs Play a Role in Decreasing Bone Mineral Density?

(2011) Fonda Chen et al.   Journal of the American Medical Directors Association

Lrp5 functions in bone to regulate bone mass

(2011) Yajun Cui et al.   NATURE MEDICINE

Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies

(2011) Q. Wu et al.   OSTEOPOROSIS INTERNATIONAL

Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels

(2010) Stuart J. Warden et al.   BONE

Cellular and Molecular Mechanisms of Bone Remodeling

(2010) Liza J. Raggatt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The two faces of serotonin in bone biology

(2010) Patricia Ducy et al.   JOURNAL OF CELL BIOLOGY

Update in Serotonin and Bone

(2010) Michael Bliziotes   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Depression, Selective Serotonin Reuptake Inhibitors, and Osteoporosis

(2010) Itai Bab et al.   Current Osteoporosis Reports

Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis

(2009) Raz Yirmiya et al.   BIOLOGICAL PSYCHIATRY

Effects of selective serotonin reuptake inhibitors on bone health in adults: Time for recommendations about screening, prevention and management?

(2009) Elizabeth M. Haney et al.   BONE

A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure

(2009) Vijay K. Yadav et al.   CELL

Selective Serotonin Reuptake Inhibiting Antidepressants Are Associated With an Increased Risk of Nonvertebral Fractures

(2009) Gijsbertus Ziere et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Depression and low bone mineral density: a meta-analysis of epidemiologic studies

(2009) Q. Wu et al.   OSTEOPOROSIS INTERNATIONAL

Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum

(2008) Vijay K. Yadav et al.   CELL

Depression and Bone Metabolism

(2008) Lana J. Williams et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation

(2007) C. Collet et al.   FASEB JOURNAL